355 related articles for article (PubMed ID: 20178618)
21. Identification of EnvC and Its Cognate Amidases as Novel Determinants of Intrinsic Resistance to Cationic Antimicrobial Peptides.
Oguri T; Yeo WS; Bae T; Lee H
Antimicrob Agents Chemother; 2016 Apr; 60(4):2222-31. PubMed ID: 26810659
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics.
Sang Y; Blecha F
Anim Health Res Rev; 2008 Dec; 9(2):227-35. PubMed ID: 18983725
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides.
Rieg S; Kaasch AJ; Wehrle J; Hofmann SC; Szymaniak-Vits M; Saborowski V; Jonas D; Kalbacher H; Seifert H; Kern WV
Microbes Infect; 2011 Aug; 13(8-9):761-5. PubMed ID: 21473929
[TBL] [Abstract][Full Text] [Related]
24. Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production.
Schlievert PM; Kilgore SH; Beck LA; Yoshida T; Klingelhutz AJ; Leung DYM
mSphere; 2023 Feb; 8(1):e0057622. PubMed ID: 36598227
[TBL] [Abstract][Full Text] [Related]
25. Capsule expression in Streptococcus mitis modulates interaction with oral keratinocytes and alters susceptibility to human antimicrobial peptides.
Rukke HV; Engen SA; Schenck K; Petersen FC
Mol Oral Microbiol; 2016 Aug; 31(4):302-13. PubMed ID: 26255868
[TBL] [Abstract][Full Text] [Related]
26. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel host defense peptides and the absence of alpha-defensins in the bovine genome.
Fjell CD; Jenssen H; Fries P; Aich P; Griebel P; Hilpert K; Hancock RE; Cherkasov A
Proteins; 2008 Nov; 73(2):420-30. PubMed ID: 18442133
[TBL] [Abstract][Full Text] [Related]
28. Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis.
Ting DSJ; Goh ETL; Mayandi V; Busoy JMF; Aung TT; Periayah MH; Nubile M; Mastropasqua L; Said DG; Htoon HM; Barathi VA; Beuerman RW; Lakshminarayanan R; Mohammed I; Dua HS
Sci Rep; 2021 Sep; 11(1):18304. PubMed ID: 34526600
[TBL] [Abstract][Full Text] [Related]
29. Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides.
Kooi C; Sokol PA
Microbiology (Reading); 2009 Sep; 155(Pt 9):2818-2825. PubMed ID: 19542010
[TBL] [Abstract][Full Text] [Related]
30. Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp.
Tomasinsig L; Skerlavaj B; Scarsini M; Guida F; Piccinini R; Tossi A; Zanetti M
J Pept Sci; 2012 Feb; 18(2):105-13. PubMed ID: 22083804
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial peptides.
Lu W
Semin Cell Dev Biol; 2019 Apr; 88():105-106. PubMed ID: 29859256
[No Abstract] [Full Text] [Related]
32. Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.
Rowe-Magnus DA; Kao AY; Prieto AC; Pu M; Kao C
mBio; 2019 Sep; 10(5):. PubMed ID: 31506312
[TBL] [Abstract][Full Text] [Related]
33. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.
Hashemi-Shahraki A; Heidarieh P; Bostanabad SZ; Hashemzadeh M; Feizabadi MM; Schraufnagel D; Mirsaeidi M
Sci Rep; 2015 Dec; 5():17862. PubMed ID: 26638771
[TBL] [Abstract][Full Text] [Related]
34. Compositional modification of nascent in vitro dental plaques by human host-defence peptides.
Madhwani T; McBain AJ
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):374-81. PubMed ID: 22171654
[TBL] [Abstract][Full Text] [Related]
35. Expression and activity of beta-defensins and LL-37 in the developing human lung.
Starner TD; Agerberth B; Gudmundsson GH; McCray PB
J Immunol; 2005 Feb; 174(3):1608-15. PubMed ID: 15661923
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial peptides and peptide antibiotics].
Bals R
Med Klin (Munich); 2000 Sep; 95(9):496-502. PubMed ID: 11028166
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
Lai CC; Tan CK; Lin SH; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
J Antimicrob Chemother; 2009 Jul; 64(1):73-8. PubMed ID: 19398458
[TBL] [Abstract][Full Text] [Related]
38. Synergistic actions of antibacterial neutrophil defensins and cathelicidins.
Nagaoka I; Hirota S; Yomogida S; Ohwada A; Hirata M
Inflamm Res; 2000 Feb; 49(2):73-9. PubMed ID: 10738945
[TBL] [Abstract][Full Text] [Related]
39. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response.
Dorschner RA; Lin KH; Murakami M; Gallo RL
Pediatr Res; 2003 Apr; 53(4):566-72. PubMed ID: 12612195
[TBL] [Abstract][Full Text] [Related]
40. Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus.
Crack LR; Jones L; Malavige GN; Patel V; Ogg GS
Clin Exp Dermatol; 2012 Jul; 37(5):534-43. PubMed ID: 22639919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
